Gland Pharma Financials
NSE: GLAND | BSE: 543245
₹2,932.40
₹24.50
(0.84%)
As on 04-Sep-2026 15:59IST
Market cap
₹48,375 Cr
Revenue (TTM)
₹6,725 Cr
P/E Ratio
42.9
P/B Ratio
4.6
Div. Yield
0.7 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
6,725.30
|
6,430.65
|
5,616.50
|
5,664.72
|
3,624.60
|
4,400.71
|
|
|
|
|
|
|
Total Income
|
7,045.33
|
6,746.98
|
5,830.11
|
5,834.96
|
3,865.06
|
4,624.65
|
|
|
|
|
|
|
Total Expenditure
|
4,974.15
|
4,801.11
|
4,347.58
|
4,331.65
|
2,599.84
|
2,890.56
|
|
|
|
|
|
|
EBITDA
|
1,751.15
|
1,629.54
|
1,268.92
|
1,333.07
|
1,024.76
|
1,510.15
|
|
|
|
|
|
|
Depreciation
|
433.87
|
423.67
|
377.87
|
344.57
|
146.74
|
110.30
|
|
|
|
|
|
|
EBIT
|
1,317.28
|
1,205.88
|
891.05
|
988.51
|
878.03
|
1,399.86
|
|
|
|
|
|
|
Interest
|
26.14
|
33.28
|
42.00
|
26.20
|
7.45
|
5.24
|
|
|
|
|
|
|
Other Income
|
320.03
|
316.33
|
213.61
|
170.24
|
240.46
|
223.94
|
|
|
|
|
|
|
Exceptional Items
|
-24.35
|
-24.35
|
--
|
--
|
-56.46
|
--
|
|
|
|
|
|
|
Profit before Tax
|
1,586.82
|
1,464.58
|
1,062.66
|
1,132.54
|
1,054.58
|
1,618.55
|
|
|
|
|
|
|
Provision for Tax
|
458.02
|
437.26
|
364.13
|
360.08
|
273.54
|
406.89
|
|
|
|
|
|
|
Profit after Tax
|
1,128.79
|
1,027.32
|
698.53
|
772.46
|
781.04
|
1,211.66
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,128.79
|
1,027.32
|
698.53
|
772.46
|
781.04
|
1,211.66
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
10,357.95
|
10,357.95
|
9,150.74
|
8,723.84
|
7,958.72
|
7,157.62
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
544.50
|
482.17
|
457.27
|
488.60
|
89.68
|
93.98
|
|
|
|
|
|
|
Current Liabilities
|
1,608.40
|
1,608.40
|
1,564.85
|
1,398.36
|
729.13
|
582.03
|
|
|
|
|
|
|
Total Liabilities
|
12,510.85
|
12,448.52
|
11,172.85
|
10,610.81
|
8,777.54
|
7,833.62
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
4,858.96
|
4,921.74
|
4,389.91
|
4,965.66
|
1,876.73
|
1,981.54
|
|
|
|
|
|
|
Current Assets
|
7,526.79
|
7,526.79
|
6,782.94
|
5,645.15
|
6,900.81
|
5,852.08
|
|
|
|
|
|
|
Total Assets
|
12,510.85
|
12,448.52
|
11,172.85
|
10,610.81
|
8,777.54
|
7,833.62
|
|
|
|
|
|
|
Total Debt*
|
--
|
243.36
|
269.21
|
319.78
|
3.82
|
3.93
|
|
|
|
|
|
|
Net Current Assets
|
5,918.38
|
5,918.38
|
5,218.09
|
4,246.79
|
6,171.68
|
5,270.05
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
10.12
|
21.38
|
15.58
|
22.07
|
12.76
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,031.39
|
914.73
|
996.80
|
363.97
|
790.77
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
137.73
|
1,704.74
|
-1,756.91
|
1,208.19
|
-1,002.62
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-416.97
|
-433.48
|
-799.42
|
14.92
|
34.90
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
752.14
|
2,185.99
|
-1,559.53
|
1,587.08
|
-176.95
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
69.56
|
62.35
|
42.40
|
46.90
|
47.42
|
73.75
|
|
|
|
|
|
|
Cash EPS (₹)
|
68.43
|
88.07
|
65.33
|
67.82
|
56.33
|
80.46
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
644.34
|
625.91
|
555.40
|
529.56
|
483.12
|
434.84
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.68
|
20.00
|
18.00
|
20.00
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
62.60
|
55.52
|
60.52
|
22.10
|
48.13
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
42.61
|
41.04
|
40.41
|
17.41
|
24.76
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
14.96
|
11.97
|
13.63
|
14.04
|
24.85
|
|
|
|
|
|
|
ROE (%)
|
11.51
|
10.56
|
7.82
|
9.26
|
10.34
|
18.61
|
|
|
|
|
|
|
ROA (%)
|
9.51
|
8.70
|
6.41
|
7.97
|
9.40
|
16.91
|
|
|
|
|
|
|
EBIT Margin (%)
|
19.59
|
18.75
|
15.86
|
17.45
|
24.22
|
31.81
|
|
|
|
|
|
|
Net Margin (%)
|
16.02
|
15.23
|
11.98
|
13.24
|
20.21
|
26.20
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
22.56
|
19.16
|
19.72
|
25.60
|
30.04
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
17.57
|
14.50
|
-0.85
|
56.29
|
-17.64
|
27.08
|
|
|
|
|
|
|
EBIT Growth (%)
|
33.69
|
35.33
|
-9.86
|
12.58
|
-37.28
|
16.32
|
|
|
|
|
|
|
Net Profit Growth (%)
|
24.36
|
47.07
|
-9.57
|
-1.10
|
-35.54
|
21.54
|
|
|
|
|
|
|
EPS Growth (%)
|
22.72
|
47.07
|
-9.60
|
-1.11
|
-35.70
|
21.01
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
12.70
|
4.91
|
9.62
|
11.38
|
21.55
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
42.86
|
27.22
|
37.55
|
39.27
|
26.75
|
44.33
|
|
|
|
|
|
|
Price / Book Value
|
4.55
|
2.71
|
2.87
|
3.48
|
2.63
|
7.52
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.68
|
1.18
|
1.13
|
1.09
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
21.85
|
12.77
|
16.15
|
19.17
|
13.54
|
29.19
|
|
|
|
|
|
|
Close Price (₹)
|
2,495.00
|
1,696.10
|
1,592.40
|
1,845.25
|
1,268.25
|
3,272.65
|
|
|
|
|
|
|
High Price (₹)
|
2,529.30
|
2,131.00
|
2,220.95
|
2,195.75
|
3,559.40
|
4,350.00
|
|
|
|
|
|
|
Low Price (₹)
|
1,573.60
|
1,200.00
|
1,411.10
|
861.00
|
1,130.00
|
2,400.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
48,374.82
|
27,964.97
|
26,233.01
|
30,337.99
|
20,894.01
|
53,712.13
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.02
|
0.03
|
0.04
|
0.00
|
0.00
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
4.68
|
4.68
|
4.33
|
4.04
|
9.46
|
10.05
|
|
|
|
|
|
|
Quick Ratio
|
3.60
|
3.60
|
3.26
|
2.85
|
6.80
|
8.02
|
|
|
|
|
|
|
Interest Coverage
|
61.70
|
45.01
|
26.30
|
44.23
|
142.61
|
309.77
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
28.12
|
29.41
|
27.00
|
27.52
|
24.04
|
24.42
|
|
|
|
|
|
|
Asset Turnover
|
0.57
|
0.54
|
0.52
|
0.58
|
0.44
|
0.61
|
|
|
|
|
|
|
Receivable days
|
--
|
96.72
|
99.92
|
78.29
|
97.99
|
72.40
|
|
|
|
|
|
|
Inventory Days
|
--
|
97.32
|
108.54
|
116.00
|
157.65
|
102.05
|
|
|
|
|
|
|
Payable days
|
--
|
134.60
|
138.65
|
113.80
|
113.72
|
74.34
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
59.43
|
69.81
|
80.48
|
141.92
|
100.11
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
